Gut Microbiome Alterations Associated with Immunosenescence and Their Potential Implications for Older Adults with Inflammatory Bowel Disease: A Scoping Review Protocol

The immune system remodelling which occurs with aging, known as immunosenescence, is an important consideration when working with the elderly patient population. Immunosenescence is characterized by a functional decline of an individual’s immune system, and is associated with increased baseline inflammation, known as ‘inflammaging’. Immunosenescence is additionally associated with altered gut microbiota compositions that may be disadvantageous to aging and elderly individuals. These compositional shifts may lead to detrimental health implications, and may be associated with increased intestinal permeability, increased bacterial translocation and increased inflammation. Due to the associated health implications, the potential microbiota compositional shifts that may coincide with aging processes are an important consideration for the elderly patient population. As immunosenescence may heighten the complexity of disease course through microbiota dysbiosis and heightened baseline inflammation, understanding the implications associated with immunosenescence is crucial for elderly disease knowledge and treatment. Microbiota compositional changes associated with immunosenescence should be considered in the aging and elderly Inflammatory Bowel Disease (IBD) patient population. IBD encompasses Crohn’s Disease (CD) and ulcerative colitis (UC), which are both chronic immune-mediated diseases which affect the gastrointestinal tract. IBD is characterized by chronic inflammation of the gastrointestinal tract and is associated with active periods of disease, referred to as ‘flares’, and inactive disease periods referred to as ‘remission’. The gastrointestinal tract harbours a dense microbial community and may contribute to localized intestinal inflammation. Therefore, microbiome research is crucial in understanding IBD disease pathogenesis. While existing literature exists on the potential role of the microbiome and IBD pathogenesis, limited evidence exists around the aging microbiome, and how it alongside immunosenescence may alter IBD pathogenesis and patient outcomes in patients aging with IBD. As prevalence of elderly IBD is increasing in Canada, this marks a significant gap in the field and signals an area of research which will be beneficial for a continuously growing patient population. The objective of this scoping review is to identify and present the available information on any gut microbiota changes associated with immunosenescence and inflammaging and discuss how these potential compositional changes may have health implications for elderly patients with existing inflammatory bowel disease. This scoping review will ultimately map and summarize existing evidence around the gut microbiome and immunosenescence, and work to inform future research around elderly IBD.

Authors

Publication Details

Journal
OSF Preprints (OSF Preprints)
Published
2026-11-16
DOI
https://doi.org/10.17605/osf.io/pbtr4
Primary Topic
Gut microbiota and health
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Gut Microbiome Alterations Associated with Immunosenescence and Their Potential Implications for Older Adults with Inflammatory Bowel Disease: A Scoping Review Protocol

David Aguirre-Villarreal, Farhad Peerani, Liz Dennett, Cassandra Rae-Lynn Popoff et al.
1 links
OSF Preprints (OSF Preprints)
Gut microbiota and health
preprint

Gut Microbiome Alterations Associated with Immunosenescence and Their Potential Implications for Older Adults with Inflammatory Bowel Disease: A Scoping Review Protocol

David Aguirre-Villarreal, Farhad Peerani, Liz Dennett, Cassandra Rae-Lynn Popoff, Karen Madsen
preprint en

Abstract

The immune system remodelling which occurs with aging, known as immunosenescence, is an important consideration when working with the elderly patient population. Immunosenescence is characterized by a functional decline of an individual’s immune system, and is associated with increased baseline inflammation, known as ‘inflammaging’. Immunosenescence is additionally associated with altered gut microbiota compositions that may be disadvantageous to aging and elderly individuals. These compositional shifts may lead to detrimental health implications, and may be associated with increased intestinal permeability, increased bacterial translocation and increased inflammation. Due to the associated health implications, the potential microbiota compositional shifts that may coincide with aging processes are an important consideration for the elderly patient population. As immunosenescence may heighten the complexity of disease course through microbiota dysbiosis and heightened baseline inflammation, understanding the implications associated with immunosenescence is crucial for elderly disease knowledge and treatment. Microbiota compositional changes associated with immunosenescence should be considered in the aging and elderly Inflammatory Bowel Disease (IBD) patient population. IBD encompasses Crohn’s Disease (CD) and ulcerative colitis (UC), which are both chronic immune-mediated diseases which affect the gastrointestinal tract. IBD is characterized by chronic inflammation of the gastrointestinal tract and is associated with active periods of disease, referred to as ‘flares’, and inactive disease periods referred to as ‘remission’. The gastrointestinal tract harbours a dense microbial community and may contribute to localized intestinal inflammation. Therefore, microbiome research is crucial in understanding IBD disease pathogenesis. While existing literature exists on the potential role of the microbiome and IBD pathogenesis, limited evidence exists around the aging microbiome, and how it alongside immunosenescence may alter IBD pathogenesis and patient outcomes in patients aging with IBD. As prevalence of elderly IBD is increasing in Canada, this marks a significant gap in the field and signals an area of research which will be beneficial for a continuously growing patient population. The objective of this scoping review is to identify and present the available information on any gut microbiota changes associated with immunosenescence and inflammaging and discuss how these potential compositional changes may have health implications for elderly patients with existing inflammatory bowel disease. This scoping review will ultimately map and summarize existing evidence around the gut microbiome and immunosenescence, and work to inform future research around elderly IBD.

OSF Preprints (OSF Preprints)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon